Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Cholamandalam Financial Holdings Ltd

CHOLAHLDNG
Finance - Holding Company

Cholamandalam Financial Holdings Ltd's earnings have outrun its stock. EPS grew +12.3% in a year against a −16.1% price move.

The sharpest disagreement: annual EPS moved +12.3% against a −16.1% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (26 weeks in) while the P/BV sits at the 13th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +19.4% year on year, with the the net margin at 15.7%. What settles it: whether the price catches up with earnings that have already moved.

Stage
Consistent
partial read
Price
₹1,533
−16.1% 1Y
P/BV
1.9×
13th pctile
of its own 10-year range
Revenue (Mar 26)
₹10,366 Cr
+16.3% YoY
Profit (Mar 26)
₹1,626 Cr
+19.4% YoY
Net margin
15.7%
+0.4 pp YoY
ROE
17%
FY26
Withheld from this page: Part of this page is deliberately not drawn: its two data sources disagree by up to 58% on reported income across 14 comparable periods, so nothing from the second source is placed here — the PEG ratio and its quarterly curve, the quarterly return-on-equity and return-on-assets curves, the annual return-on-assets overlay and the F-score are absent for that reason. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Cholamandalam Financial Holdings Ltd trades at ₹1,533, in a downtrend and 26 weeks into that stage. That is −7.5% against its own 200-day average. It sits at 23% of a 52-week range of ₹1,385 to ₹2,017. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week.

Today the stock is in a downtrend — week 26 of stage 4, confirmed. At ₹1,533 it trades −7.5% versus its 200-day average and sits at 23% of its 52-week range (₹1,385–₹2,017).

Jul 26: ₹1,533 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−7.5% versus the 200-day line, week 26 of stage 4
Price50-day avg200-day avg
S2S2S4₹2,230₹1,826₹1,422₹1,018₹614₹1,533₹1,656Jul 23May 24Feb 25Nov 25Jul 26
S2S2S4₹2,230₹1,826₹1,422₹1,018₹614₹1,533₹1,656Jul 23Feb 25Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (544 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +442% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.

Cholamandalam Financial Holdings Ltd trades at 1.9× P/BV, near the bottom of its own range — cheaper only 13% of the time. Its long-run median P/BV is 2.4×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/BV of 1.9× is near the bottom of its own range — cheaper only 13% of the time, against a long-run median of 2.4× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/BV 1.9× vs a 2.4× long-run median P/BV, weekly (left axis); book value per share, weekly (right axis). 10.4-year window; brief peaks above 4.6× shown pinned at the top. The book value / share bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 13% of the time
P/BVMedianBook value / share (quarterly)
4.9×₹8713.9×₹6532.9×₹4361.9×₹2180.9×₹0.0×1.90×₹807Mar 16Nov 18Jul 21Feb 24Jul 26
4.9×₹8713.9×₹6532.9×₹4361.9×₹2180.9×₹0.0×1.90×₹807Mar 16Jul 21Jul 26
P/BV
1.9×
13th percentile of 10y

Why the multiple sits where it does: over the past year book value grew while the price moved −16.1% — price and book moved together, holding the multiple in its range.

The price move, decomposed: over 5y, of the +18.4%/yr price move, ~+23.0%/yr came from book-value growth and ~−4.6 pp from the multiple (compressing); over 10y, of the +14.9%/yr price move, ~+16.6%/yr came from book-value growth and ~−1.7 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.

The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 58% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

03 · Stage: Consistent

Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Cholamandalam Financial Holdings Ltd reads as consistent on its fundamental arc. Consistent — revenue and profit growth have stayed positive through the window, with ROE at 17.0% and holding. The read is built from 10 quarters across 3 curves, on partial evidence.

Growth, year by year: revenue +18.0% in FY26, profit +15.7% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
255%161%169%102%83%44%−3.9%−14%−90%−72%%%18%15.7%FY16FY21FY26
255%161%169%102%83%44%−3.9%−14%−90%−72%%%18%15.7%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue rolling over, profit rolling over
RevenueProfitEPS
46%50%38%38%30%26%22%15%14%3.2%%%16.3%19.4%12.3%Jun 23Sep 24Mar 26
46%50%38%38%30%26%22%15%14%3.2%%%16.3%19.4%12.3%Jun 23Sep 24Mar 26
ROE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROE
20.2%19.4%18.5%17.6%16.8%%17%FY23FY24FY26
20.2%19.4%18.5%17.6%16.8%%17%FY23FY24FY26
Revenue growth
Steady high
latest +16.3% · span +16.3% to +36.3%
Profit growth
Rising
latest +19.4% · span +6.4% to +42.6%
ROE
Steady high
latest 17.0% · span 17.0%–20.0%

Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+18.0%+29.2%+23.0%+17.2%
Profit+15.7%+25.0%+25.5%+16.6%
EPS+12.3%+23.7%+24.2%+8.9%
Share price−16.1%+18.1%+18.4%+14.9%
Revenue YoY (Mar 26)
+16.3%
latest quarter vs a year ago
Profit YoY (Mar 26)
+19.4%
latest quarter vs a year ago
Revenue 10y
17.2%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

56.8/100 — rank 5 of 18 in Finance - Holding Company · 76% evidence confidence

Cholamandalam Financial Holdings Ltd scores 56.8 out of 100 against the 18 companies it is compared with in Finance - Holding Company, ranking 5. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 19 + 18 + 15.2 + 4.6 = 56.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.

05 · Revenue

Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.

Cholamandalam Financial Holdings Ltd reported ₹10,366 Cr of income in the Mar 26 quarter, +16.3% year on year. That is the 10th straight quarter of year-on-year growth. Over 10 years it has compounded at 17.2% a year. The last full year, FY26, came in at ₹39,156 Cr. The last four reported quarters add to ₹39,072 Cr.

FY26 revenue came in at ₹39,156 Cr (+18.0% on the year), capping 10 years at 17.2% compound. The latest quarter (Mar 26) printed ₹10,366 Cr, +16.3% year on year — the 10th consecutive quarter of year-over-year growth.

FY26 revenue ₹39,156 Cr (+18.0% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
17.2% a year over 10 years
RevenueYoY growth
42.3k255%31.7k169%21.1k83%10.6k−3.9%0−90%₹ Cr%₹39,15618%FY16FY21FY26
42.3k255%31.7k169%21.1k83%10.6k−3.9%0−90%₹ Cr%₹39,15618%FY16FY21FY26
Mar 26: ₹10,366 Cr (+16.3% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
10th straight quarter of growth
Revenue (quarterly)YoY growth
11.2k46%8.4k38%5.6k30%2.8k22%014%₹ Cr%₹10,36616.3%Jun 23Sep 24Mar 26
11.2k46%8.4k38%5.6k30%2.8k22%014%₹ Cr%₹10,36616.3%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +18.1% growth against the decade's 17.2% — the current year is running in line with its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +18.0% over the last 4 quarters against +23.1%/yr over the last 8 — rolling over; TTM profit +15.7% vs +19.4%/yr — rolling over.

06 · Net margin

Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.

Cholamandalam Financial Holdings Ltd's net margin is 15.7% in the Mar 26 quarter, +0.4 percentage points against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 5.9% to 20.0%. The current quarter sits inside that band.

The latest quarter's net margin is 15.7%, +0.4 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 5.9%–20.0%.

Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.

FY26: 14.0% Net margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 5.9–20.0% band over 13 years
net marginYoY change (pp)
21%8.9%17%4.6%13%0.2%8.9%−4.1%4.8%−8.5%%%14%−0.3%FY14FY20FY26
21%8.9%17%4.6%13%0.2%8.9%−4.1%4.8%−8.5%%%14%−0.3%FY14FY20FY26
Mar 26: 15.7% net margin (+0.4 pp YoY) Quarterly net margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Net profit as a share of total revenue, per quarter.
Net marginYoY change (pp)
16.5%1.4%15.5%0.4%14.5%−0.6%13.5%−1.5%12.5%−2.5%%%15.7%0.4%Jun 23Sep 24Mar 26
16.5%1.4%15.5%0.4%14.5%−0.6%13.5%−1.5%12.5%−2.5%%%15.7%0.4%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Cholamandalam Financial Holdings Ltd earned ₹1,626 Cr of net profit in the Mar 26 quarter, +19.4% year on year. It is the 10th consecutive quarter of growth. Full-year FY26 profit was ₹5,485 Cr. The 10-year compound rate is 16.6%. That is 15.7% of the quarter's revenue. The same quarter a year earlier earned ₹1,362 Cr.

Mar 26 profit was ₹1,626 Cr, +19.4% year on year — the 10th consecutive quarter of growth. On the full year, FY26 printed ₹5,485 Cr (+15.7%), and the 10-year compound rate is 16.6%.

FY26 profit ₹5,485 Cr (+15.7% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
16.6% a year over 10 years
Net profitYoY growth
5.9k123%4.4k75%3.0k28%1.5k−20%0−68%₹ Cr%₹5,48515.7%FY16FY21FY26
5.9k123%4.4k75%3.0k28%1.5k−20%0−68%₹ Cr%₹5,48515.7%FY16FY21FY26
Mar 26: ₹1,626 Cr (+19.4% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
10th straight quarter of growth
Net profit (quarterly)YoY growth
1.8k50%1.3k38%87826%43915%03.2%₹ Cr%₹1,62619.4%Jun 23Sep 24Mar 26
1.8k50%1.3k38%87826%43915%03.2%₹ Cr%₹1,62619.4%Jun 23Sep 24Mar 26

Why profit moved: revenue contributed +16.3% and the margin +0.4 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +15.7% vs revenue +18.1%. Profit and revenue are moving roughly in step.

08 · Asset quality — the ladder

Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.

Loan-book quality history is not available for Cholamandalam Financial Holdings Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.

We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.

Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.

09 · The loan book

The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.

Cholamandalam Financial Holdings Ltd's revenue grew +18.0% in FY26 to ₹39,156 Cr, so the book is growing. The latest quarter ran +16.3% year on year. The net margin on that income is 15.7%, +0.4 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.

FY26 revenue was ₹39,156 Cr, +18.0% on the year, and the latest quarter ran +16.3% year on year. The net margin on that revenue is 15.7% this quarter (+0.4 pp YoY) — growth with a widening margin on it.

FY26: revenue ₹39,156 Cr (+18.0% YoY) with the net margin at 14.0% Revenue by fiscal year, ₹ Cr (bars, left); net margin, % (line, right). 11-year window. A bar is red when it is lower than the year before.
RevenueNet margin
42.3k21%31.7k18%21.1k14%10.6k11%08.0%₹ Cr%₹39,15614%FY16FY18FY21FY23FY26
42.3k21%31.7k18%21.1k14%10.6k11%08.0%₹ Cr%₹39,15614%FY16FY21FY26

The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.

10 · Returns on equity and assets

Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.

Cholamandalam Financial Holdings Ltd earns a return on equity of 17% in FY26. Its trough over the ladder below was 13% in FY20. For a lender the balance sheet is the operating asset, so equity return and asset return have to be read together.

FY26 ROE came in at 17%, recovered from a FY20 trough of 13%. On assets, the latest reading is about null% — every ₹100 the bank deploys earns roughly null a year. That clears the bar a bank must beat for its book value to compound.

FY26: ROE 17% Return on equity by fiscal year, % (line, left). 13-year window. Latest return on assets: null%. A lender is judged on ROE and ROA — return on invested capital does not apply to a bank.
up from a FY20 trough of 13%
ROE
22%19%17%15%12%%17%FY14FY17FY20FY23FY26
22%19%17%15%12%%17%FY14FY20FY26

Why ROE moved: profit compounded 16.6% a year over 10 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.

The quarterly return-on-equity and return-on-assets curves, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 58% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

11 · Debt

Debt

For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.

A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.

12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Domestic institutions added 1.4 points of Cholamandalam Financial Holdings Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 26.9% of the company. Promoters moved −0.9 points over the same window, to 46.4%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Domestic institutions: +1.4 points over 8 quarters to 26.9%; Promoters: −0.9 points over 8 quarters to 46.4%; Foreign institutions: −0.7 points over 8 quarters to 13.0%.

Why the register moved: domestic institutions drove it (+1.4 points), absorbed on the other side by promoters (−0.9 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters −1.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
50%40%30%20%10%%46.4%13.8%26.1%13.3%Mar 24Mar 25Mar 26
50%40%30%20%10%%46.4%13.8%26.1%13.3%Mar 24Mar 25Mar 26
Domestic institutions added 1.4 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
51%41%30%19%8.3%%46.4%13%26.9%13.2%Jun 23Dec 24Jun 26
51%41%30%19%8.3%%46.4%13%26.9%13.2%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Cholamandalam Financial Holdings Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.

The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.

14 · Related companies · Finance - Holding Company
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Jindal Poly Investment & Finance Company LtdJPOLYINVST 79.8/100Favorable setup76% evidence ASLEEP 30.0/35 Income 100% · PAT 100% 71% evidence 20.7/25 ROA 47.9% · ROE 54.8% · GNPA — 68% evidence 14.5/20 P/BV 0.67× · P/BV÷ROE 0.01 100% evidence 14.6/20 RS sector 32.3% · RS bench -2.4% · 1Y 28%0 of 10 weeks ahead 70% evidence
Exact sum: 30 + 20.7 + 14.5 + 14.6 = 79.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2Kama Holdings LtdKAMAHOLD 68.3/100Favorable setup78% evidence ASLEEP 24.3/35 Income 7.4% · PAT 47% 75% evidence 17.8/25 ROA 7.3% · ROE 12.7% · GNPA — 72% evidence 18.1/20 P/BV 1.01× · P/BV÷ROE 0.08 100% evidence 8.1/20 RS sector -0.5% · RS bench -9.8% · 1Y -18.1%1 of 10 weeks ahead 70% evidence
Exact sum: 24.3 + 17.8 + 18.1 + 8.1 = 68.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3TVS Holdings LtdTVSHLTD 65.3/100Favorable setup67% evidence TURNING 25.2/35 Income 31.7% · PAT 49.4% 52% evidence 16.2/25 ROA — · ROE 30.6% · GNPA — 34% evidence 10.3/20 P/BV 4.6× · P/BV÷ROE 0.15 100% evidence 13.6/20 RS sector 4.5% · RS bench 3.8% · 1Y 22.9%0 of 12 weeks ahead 100% evidence
Exact sum: 25.2 + 16.2 + 10.3 + 13.6 = 65.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Godrej Industries LtdGODREJIND 59.5/100Mixed-positive evidence73% evidence LEADER 20.8/35 Income 13.1% · PAT 29.8% 45% evidence 14.1/25 ROA 1.9% · ROE 9.3% · GNPA — 68% evidence 5.1/20 P/BV 3.97× · P/BV÷ROE 0.43 100% evidence 19.5/20 RS sector 22% · RS bench 20.7% · 1Y 16%12 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 14.1 + 5.1 + 19.5 = 59.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Cholamandalam Financial Holdings Ltdthis pageCHOLAHLDNG 56.8/100Mixed-positive evidence76% evidence ASLEEP 19.0/35 Income 17.9% · PAT 15.7% 55% evidence 18.0/25 ROA 2.2% · ROE 17.5% · GNPA — 68% evidence 15.2/20 P/BV 1.86× · P/BV÷ROE 0.11 100% evidence 4.6/20 RS sector -10.9% · RS bench -12.1% · 1Y -23%3 of 12 weeks ahead 100% evidence
Exact sum: 19 + 18 + 15.2 + 4.6 = 56.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Bajaj Finserv LtdBAJAJFINSV 54.4/100Mixed-positive evidence61% evidence TURNING 18.2/35 Income 14.5% · PAT 10.5% 52% evidence 14.8/25 ROA — · ROE 13.2% · GNPA — 34% evidence 8.0/20 P/BV 4.17× · P/BV÷ROE 0.32 100% evidence 13.4/20 RS sector 2.1% · RS bench 3.8% · 1Y 2.2%1 of 10 weeks ahead 70% evidence
Exact sum: 18.2 + 14.8 + 8 + 13.4 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Alembic LtdALEMBICLTD 52.8/100Mixed-positive evidence78% evidence ASLEEP 11.8/35 Income 8.1% · PAT 2.3% 75% evidence 18.1/25 ROA 12.2% · ROE 13% · GNPA — 72% evidence 16.7/20 P/BV 0.96× · P/BV÷ROE 0.07 100% evidence 6.2/20 RS sector -10.9% · RS bench -5.3% · 1Y -20.8%1 of 10 weeks ahead 70% evidence
Exact sum: 11.8 + 18.1 + 16.7 + 6.2 = 52.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
8Bajaj Holdings & Investment LtdBAJAJHLDNG 52.3/100Mixed-positive evidence61% evidence TURNING 18.1/35 Income 30.3% · PAT 5.6% 52% evidence 13.8/25 ROA — · ROE 11.9% · GNPA — 34% evidence 12.3/20 P/BV 1.73× · P/BV÷ROE 0.14 100% evidence 8.1/20 RS sector -9.6% · RS bench -0.7% · 1Y -18.1%1 of 11 weeks ahead 70% evidence
Exact sum: 18.1 + 13.8 + 12.3 + 8.1 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Tata Investment Corporation LtdTATAINVEST 49.3/100Mixed-negative evidence78% evidence ASLEEP 25.3/35 Income 30.6% · PAT 38.3% 75% evidence 11.2/25 ROA 1.3% · ROE 1.4% · GNPA — 72% evidence 3.9/20 P/BV 1.17× · P/BV÷ROE 0.81 100% evidence 8.9/20 RS sector -1.1% · RS bench -4.8% · 1Y 2.6%2 of 10 weeks ahead 70% evidence
Exact sum: 25.3 + 11.2 + 3.9 + 8.9 = 49.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Maharashtra Scooters LtdMAHSCOOTER 44.8/100Mixed-negative evidence61% evidence TURNING 21.9/35 Income 41% · PAT 15.3% 52% evidence 10.8/25 ROA — · ROE 1.1% · GNPA — 34% evidence 3.1/20 P/BV 0.54× · P/BV÷ROE 0.51 100% evidence 9.0/20 RS sector -0.4% · RS bench -8.4% · 1Y -11%0 of 10 weeks ahead 70% evidence
Exact sum: 21.9 + 10.8 + 3.1 + 9 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Rane Holdings LtdRANEHOLDIN 44.6/100Mixed-negative evidence67% evidence TURNING 16.6/35 Income 34.9% · PAT -38.5% 45% evidence 13.9/25 ROA 4% · ROE 7% · GNPA — 68% evidence 5.1/20 P/BV 2.16× · P/BV÷ROE 0.31 100% evidence 9.0/20 RS sector -10.9% · RS bench 22.4% · 1Y 11.6%9 of 10 weeks ahead 70% evidence
Exact sum: 16.6 + 13.9 + 5.1 + 9 = 44.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Max India LtdMAXIND 40.9/100Thin evidence · provisional55% evidence TURNING 23.5/35 Income 30.8% · PAT 13.5% 45% evidence 4.0/25 ROA -18.2% · ROE -32.8% · GNPA — 68% evidence 8.3/20 P/BV 2.21× · P/BV÷ROE — 40% evidence 5.1/20 RS sector -16.6% · RS bench -5.2% · 1Y -22.8%5 of 10 weeks ahead 70% evidence
Exact sum: 23.5 + 4 + 8.3 + 5.1 = 40.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
13Vardhman Holdings LtdVHL 39.8/100Mixed-negative evidence76% evidence ASLEEP 7.4/35 Income -47.8% · PAT -15.9% 71% evidence 14.8/25 ROA 5.8% · ROE 5.9% · GNPA — 68% evidence 8.0/20 P/BV 0.29× · P/BV÷ROE 0.05 100% evidence 9.6/20 RS sector -0.3% · RS bench -6.1% · 1Y -17.2%2 of 10 weeks ahead 70% evidence
Exact sum: 7.4 + 14.8 + 8 + 9.6 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Elcid Investments LtdELCIDIN 36.3/100Mixed-negative evidence69% evidence ASLEEP 14.8/35 Income -36.8% · PAT -28.3% 48% evidence 9.7/25 ROA 1.3% · ROE 1.2% · GNPA — 72% evidence 8.6/20 P/BV 0.26× · P/BV÷ROE 0.21 70% evidence 3.2/20 RS sector -8.7% · RS bench -9.7% · 1Y -17.4%8 of 12 weeks ahead 100% evidence
Exact sum: 14.8 + 9.7 + 8.6 + 3.2 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Kalyani Investment Company LtdKICL 34.1/100Adverse evidence72% evidence TURNING 8.0/35 Income 1.3% · PAT -47.9% 75% evidence 6.3/25 ROA 0.3% · ROE 0.4% · GNPA — 72% evidence 5.0/20 P/BV 0.21× · P/BV÷ROE 0.57 70% evidence 14.8/20 RS sector 3.7% · RS bench 8.8% · 1Y 11.2%5 of 10 weeks ahead 70% evidence
Exact sum: 8 + 6.3 + 5 + 14.8 = 34.1 · Decision use: Price leads the evidence: RS versus the benchmark is 8.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
16Max Financial Services LtdMFSL 29.0/100Adverse evidence78% evidence ASLEEP 9.6/35 Income 2.6% · PAT -74% 75% evidence 6.7/25 ROA 0.1% · ROE 1.5% · GNPA — 72% evidence 0.4/20 P/BV 9.8× · P/BV÷ROE 6.45 100% evidence 12.3/20 RS sector 19.3% · RS bench -9.5% · 1Y -1.8%0 of 10 weeks ahead 70% evidence
Exact sum: 9.6 + 6.7 + 0.4 + 12.3 = 29 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17JSW Holdings LtdJSWHL 26.0/100Adverse evidence78% evidence ASLEEP 9.8/35 Income -27.1% · PAT -25.4% 75% evidence 7.8/25 ROA 0.4% · ROE 0.5% · GNPA — 72% evidence 4.4/20 P/BV 0.38× · P/BV÷ROE 0.83 70% evidence 4.0/20 RS sector -29.1% · RS bench -29.9% · 1Y -46.6%0 of 12 weeks ahead 100% evidence
Exact sum: 9.8 + 7.8 + 4.4 + 4 = 26 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Pilani Investment & Industries Corporation LtdPILANIINVS 23.1/100Adverse evidence69% evidence ASLEEP 12.0/35 Income -6.4% · PAT -68.5% 48% evidence 5.3/25 ROA 0.2% · ROE 0.2% · GNPA — 72% evidence 4.1/20 P/BV 0.3× · P/BV÷ROE 1.5 70% evidence 1.7/20 RS sector -11.5% · RS bench -12.4% · 1Y -15.7%0 of 12 weeks ahead 100% evidence
Exact sum: 12 + 5.3 + 4.1 + 1.7 = 23.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Cholamandalam Financial Holdings Ltd's share price today?

Cholamandalam Financial Holdings Ltd trades at ₹1,533, −16.1% over the past year. The company is valued at ₹28,809 Cr. The stock sits at 23% of its 52-week range of ₹1,385–₹2,017, −7.5% versus its 200-day average. On the tape, the price is in a downtrend, 26 weeks in. — as of 31 July 2026.

What were Cholamandalam Financial Holdings Ltd's latest quarterly results?

Cholamandalam Financial Holdings Ltd reported total income of ₹10,366 Cr and net profit of ₹1,626 Cr for the Mar 26 quarter. Income rose 16.3% and profit rose 19.4% year on year. Earnings per share were ₹36.59. The net margin was 15.7%, 0.4 pp higher than a year earlier. — as of 31 July 2026.

What is Cholamandalam Financial Holdings Ltd's revenue?

Cholamandalam Financial Holdings Ltd reported revenue of ₹10,366 Cr in the Mar 26 quarter, +16.3% year on year. For the full FY26 fiscal year, revenue was ₹39,156 Cr (+18.0%). Over the last 10 years revenue compounded at 17.2% a year. — as of 31 July 2026.

What is Cholamandalam Financial Holdings Ltd's profit?

Cholamandalam Financial Holdings Ltd earned ₹1,626 Cr of net profit in the Mar 26 quarter, +19.4% year on year — the 10th straight quarter of growth. Full-year FY26 profit was ₹5,485 Cr. The net margin ran 15.7% in the latest quarter. — as of 31 July 2026.

What is Cholamandalam Financial Holdings Ltd's market cap?

Cholamandalam Financial Holdings Ltd's market capitalisation is ₹28,809 Cr at a share price of ₹1,533. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is Cholamandalam Financial Holdings Ltd's P/BV ratio?

Cholamandalam Financial Holdings Ltd trades at a P/BV of 1.9×, at the 13th percentile of its own 10-year range, against a long-run median of 2.4×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does Cholamandalam Financial Holdings Ltd pay a dividend?

Yes — Cholamandalam Financial Holdings Ltd's dividend payout was 1% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.

Is Cholamandalam Financial Holdings Ltd overvalued?

On its own history, Cholamandalam Financial Holdings Ltd looks cheap against its own history: its P/BV of 1.9× has been cheaper only 13% of the time in 10 years (long-run median 2.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

Is Cholamandalam Financial Holdings Ltd growing?

Yes — Cholamandalam Financial Holdings Ltd is growing: latest-quarter revenue +16.3% year on year, profit +19.4%, and the the net margin +0.4 pp at 15.7%. The 10-year compound rates are 17.2% (revenue) and 16.6% (profit). The earnings engine currently reads: improving — as of 31 July 2026.

How is Cholamandalam Financial Holdings Ltd performing?

Cholamandalam Financial Holdings Ltd is in a downtrend, 26 weeks in. Its latest quarter's income rose 16.3% and profit rose 19.4% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 31 July 2026.

What stage is Cholamandalam Financial Holdings Ltd in?

Consistent — revenue and profit growth have stayed positive through the window, with ROE at 17.0% and holding. The read comes from the last 12 quarters of growth (revenue growth +16.3% latest, profit growth +19.4% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.

Is Cholamandalam Financial Holdings Ltd in an uptrend?

No — the price is in a downtrend (week 26 of stage 4), trading −7.5% versus its 200-day average and at 23% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is Cholamandalam Financial Holdings Ltd beating the market?

On recent form, yes — Cholamandalam Financial Holdings Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +442% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.

Will Cholamandalam Financial Holdings Ltd's share price go up?

This page publishes no price forecast for Cholamandalam Financial Holdings Ltd. What it measures instead: the share price is ₹1,533, the price is in a downtrend 26 weeks in. Its P/BV of 1.9× sits at the 13th percentile of its own 10-year range. — as of 31 July 2026.

Who owns Cholamandalam Financial Holdings Ltd?

Promoters hold 46.4% of Cholamandalam Financial Holdings Ltd, foreign institutions 13.0%, domestic institutions 26.9% and the public 13.2% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 1.4 points over 8 quarters. — as of 31 July 2026.

Is Cholamandalam Financial Holdings Ltd's loan book healthy?

We do not hold quarterly loan-book quality numbers for Cholamandalam Financial Holdings Ltd, so this page says that plainly. The cleanest available reads are revenue growth (+18.0% in FY26) and the net margin on it (15.7%) — as of 31 July 2026.

Where is Cholamandalam Financial Holdings Ltd in its business cycle?

Cholamandalam Financial Holdings Ltd's FY26 net margin was 14.0%, against a 13-year band of 5.9%–20.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 15.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Cholamandalam Financial Holdings Ltd story?

The sharpest disagreement: annual EPS moved +12.3% against a −16.1% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Cholamandalam Financial Holdings Ltd a stock worth studying right now?

This is not investment advice. The machine read: Cholamandalam Financial Holdings Ltd's earnings have outrun its stock. EPS grew +12.3% in a year against a −16.1% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI